MedTrace Logo

UK Validation of the Automated "AcceXible" Speech Analysis Software

NCT05534958 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 221

Last updated 2026-04-23

No results posted yet for this study

Summary

Dementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient will be in a position to prevent further deterioration.

A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness.

The present study has the objective of validating a digital method for detection and follow-up of patients with mild cognitive impairment (MCI) or dementia in a memory clinic setting.

Conditions

  • Mild Cognitive Impairment and Dementia

Interventions

DEVICE

Accexible

Speech Analysis

Sponsors & Collaborators

  • Accexible

    lead INDUSTRY

  • Cornwall Partnership NHS Foundation Trust

    collaborator NETWORK

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-18
Primary Completion
2024-11-12
Completion
2024-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05534958 on ClinicalTrials.gov